HB 1741 — Washington
Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.
Washington legislative agenda & upcoming votes Washington session calendar
Summary
- HB 1741 is a bill in the Washington House, 2025-2026 session, introduced January 30, 2025.
- Sponsored by Thai, with 9 cosponsors.
- Current status: introduced.
- Most recent action (January 12, 2026): By resolution, reintroduced and retained in present status.
-
State Representative, District 41
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Thai
Cosponsors (9): Leavitt, Paul, Simmons, Couture, Parshley, Fey, Duerr, Nance, Davis
History
- Introduced, completed
- Passed House, in progress
- Passed Senate, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- House First reading, referred to Health Care & Wellness.
- House By resolution, reintroduced and retained in present status. Latest